Author's articles
1Q'24 Financial Review: Revenue Decline Overshadows Cost Management Efforts
Robust 1Q24 Performance: Strong Revenue Growth and Improved Operational Efficiency
DM BOŚ SA Research Report Excerpt: Strong 1Q24 Performance Driven by Diagnostic Segment Growth
Transitional period We reiterate a BUY rating, but lowered our 12-month price target to PLN 3.7
1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts
1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts - 31.05.2024
Financial Highlights and Operational Insights: 1Q24 Performance Analysis
Sunex: Upgrading to BUY Despite Near-Term Weakness Expectations
Sunex: 4Q23 Results Review and 1Q24 Preview Amid Sales Decline
Steady Outlook Despite Market Challenges
Enhanced Dividend Policy: Semi-Annual Dividends to Foster Investor Confidence
Strategic Expansion: IMS's Ambitious Plans for 2024
Navigating Challenges: Analysis and Outlook for Artifex's "Unsolved" in 2024
Driving Growth: DataWalk's 1Q24 Preliminary Results and Investor Insights
Rebuilding Momentum: Analyzing Company Backlog and Future Prospects
Navigating Challenges: Relpol's Journey Amidst Economic Shifts
Navigating Short-Term Challenges: Company's Backlog and Prospects
Miraculum's 1Q24 Results: Strong EBITDA Growth and Improved Margins Despite Revenue Decline
